Gurnet Point Capital is an investment fund that enables established healthcare and life science businesses to accelerate growth and achieve their long-term vision.
Employees: 1-10
Portfolio 8
Date | Name | Website | Total Raised | Location |
21.08.2022 | Radius Hea... | radiusphar... | - | United Sta... |
08.12.2016 | Crossover ... | crossoverh... | $275M | United Sta... |
- | Naveris, I... | naveris.co... | $51M | United Sta... |
- | Early Alle... | spoonfulon... | - | - |
- | Innocoll | innocoll.c... | - | United Sta... |
- | Corium | corium.com | - | United Sta... |
- | Tremeau Ph... | tremeau.co... | - | United Sta... |
- | Alladapt I... | alladapt.c... | $119M | United Sta... |
Mentions in press and media 11
Date | Title | Description | Source |
21.09.2022 | Naveris Raises $51M for Early Detection of Viral-Driven Canc... | What You Should Know: Founded in 2017, Naveris is a privately held biotechnology company with facil... | hitconsult... |
27.11.2018 | Gurnet Point Capital Completes Tender Offer for Corium Inter... | Nov 27 2018 CAMBRIDGE, Mass.—(BUSINESS WIRE)—Gurnet Point Capital (“Gurnet Point”), a private inves... | ewhealthca... |
27.06.2018 | Term Sheet — Wednesday, June 27 | DATING DRAMA Good morning, Term Sheet readers. Paid Content What you need to know about growing cy... | fortune.co... |
11.06.2018 | In the heart of one of the biggest Life Sciences hubs - tale... | In the heart of one of the biggest Life Sciences hubs - tales from a Swiss entrepreneur in Boston 11... | venturelab... |
20.06.2017 | venture leaders Life Science 2017: Walk the investors’ talk... | venture leaders Life Science 2017: Walk the investors’ talk 20.06.2017 10:00, Lara Rossi linkedIn fa... | venturelab... |
20.06.2017 | venture leaders Life Science 2017: Walk the investors’ talk... | Monday: Rolling the pitch PAREXEL, 7:30AM. A short night after landing at Logan airport, the partic... | venturekic... |
08.12.2016 | Crossover Health Nabs $92M to Fuel Primary Care Technology P... | Crossover Health, an Aliso Viejo, CA-based next generation provider of employee healthcare that deve... | hitconsult... |
26.11.2015 | USD 600 million for new drugs | With a differentiated combination of proven industry expertise and dedicated capital, Boston Pharm... | startuptic... |
21.11.2015 | Gurnet Point Capital Launches Boston Pharmaceuticals with $6... | Gurnet Point Capital, an investment firm focused on the healthcare and life sciences sectors that wa... | finsmes.co... |
19.11.2015 | Ex-Sanofi CEO helps launch Boston Pharmaceuticals with $600M | Christopher Viehbacher, the former CEO of Sanofi and current Gurnet Point Capital managing partner, ... | medcitynew... |
Show more